Clinical Trials Logo

Microcirculation clinical trials

View clinical trials related to Microcirculation.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05990907 Active, not recruiting - Hemodynamics Clinical Trials

Influence of RIC on the Orthostatic Competence of the Microcirculation

Start date: July 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial (pilot study) is to learn about the microcirculatory regulation of the lower extremity under orthostatic stress with and without RIC - Remote Ischemic Preconditioning in healthy participants. The main question it aims to answer are: Do the beneficial effects of RIC withstand orthostatic stress? / Does RIC benefit lower extremity microcirculation in ortho-statically stressed subjects? Is there a relationship/correlation between the variables of microcirculation and hemodynamics in the context of RIC and orthostatic loading?

NCT ID: NCT04169204 Active, not recruiting - Intensive Care Clinical Trials

Very Old Intensive Care Patients - Perfusion

VIPPER
Start date: May 19, 2020
Phase:
Study type: Observational

Shock is a frequent, etiologically heterogeneous and often lethal clinical condition of intensive care medicine. This is particularly true for very old intensive care patients (VIPs), who are among the fastest-growing subgroups of all intensive care unit (ICU) patients and who suffer from a significantly impaired outcome. In addition to the treatment of the causes of shock, current therapeutic approaches focus on the stabilization of vital parameters, which in general all reflect macrocirculatory measured values such as blood pressure. In contrast, a disturbance of the microcirculation (blood circulation of the smaller blood vessels <100 µm) is only poorly measurable and delayed. The last generation of AVA-Software (MicroVisionMedical) will calculate different parameters about the capillary densitiv and perfusion in a user-independent way. VIPPER investigates whether a non-invasive measurement of microcirculation using the sublingual mucosa in very old intensive care patients in shock leads to faster recognition and specific treatment of organ dysfunctions. Secondly, this study checks whether this measurement predicts outcome.

NCT ID: NCT03528473 Active, not recruiting - Quality of Life Clinical Trials

Adapted Physical Activity (APA) in a Breast Cancer Population.

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of a 6-months program of Adapted Physical Activity (APA) on lifestyle, physical activity levels, insulin resistance and adipokines, oxidative stress, microcirculatory haemodynamics and serum levels of specific circulating miRNA in post-menopausal, physically inactive breast cancer patients in oncologic follow-up with or without hormone therapy that had completed adjuvant treatment (radiotherapy and/or chemotherapy) . Furthermore, the study will determine the impact of APA on functional capabilities, on self-reported physical activity, quality of life and psychic health.

NCT ID: NCT00876668 Active, not recruiting - Clinical trials for Peripheral Vascular Disease

Evaluation of the Clinical Significance of Fluorescence Videoangiography With Indocyanine-Green

Start date: June 2007
Phase: N/A
Study type: Observational

The aim of the study is to compare the diagnostic value of this non-invasive vascular imaging tool with the established vascular diagnostic methods for PAD in order to get prognostic data. A higher sensitivity of Fluorescence angiography in order to recognize progression of critical limb ischemia could lead to earlier therapeutic interventions and thereby increase limb salvage. A diagnostic gap would be closed.

NCT ID: NCT00742066 Active, not recruiting - Hypertension Clinical Trials

Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

Start date: March 2008
Phase: N/A
Study type: Interventional

In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2. Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular effects in normotensive control subjects?